Targeted Genetics went on the attack after The Washington Post raised serious criticisms of a gene therapy trial that was suspended after the death of a volunteer. But Wired also notes that the company's response avoids many of the most serious criticisms leveled in the report. Report [1]
Links:
[1] http://blog.wired.com/wiredscience/2007/08/targeted-geneti.html